US Stock MarketDetailed Quotes

Chemomab Therapeutics (CMMB)

Watchlist
  • 1.690
  • -0.010-0.59%
Close Apr 14 15:59 ET
12.17MMarket Cap-1.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chemomab Therapeutics (CMMB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
27.66%-11.13M
34.84%-15.39M
-15.91%-23.61M
-31.31%-7.49M
-93.64%-7.19M
-64.62%-20.37M
-97.06%-5.7M
-103.68%-5.26M
-1.68%-5.7M
-187.01%-3.71M
Net income from continuing operations
35.50%-9M
42.43%-13.95M
12.39%-24.22M
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
Depreciation and amortization
32.08%70K
-20.90%53K
15.52%67K
14.29%16K
23.08%16K
70.59%58K
27.27%14K
88.89%17K
100.00%14K
85.71%13K
Other non cash items
--7K
----
----
----
----
----
----
----
----
----
Change In working capital
-34.30%-2.84M
-122.68%-2.11M
-123.66%-948K
40.21%-171K
110.87%1.07M
305.59%4.01M
61.62%1.82M
3,280.65%1.97M
91.52%-286K
40.17%506K
-Change in receivables
-134.70%-1.14M
-153.93%-487K
1,510.94%903K
99.73%-3K
324.24%814K
96.89%-64K
516.09%536K
129.95%883K
56.69%-1.12M
-736.84%-363K
-Change in payables and accrued expense
22.09%-1.38M
-57.05%-1.77M
-135.50%-1.13M
-229.51%-531K
-62.68%315K
3,152.88%3.18M
48.56%1.24M
362.16%679K
145.56%410K
285.39%844K
-Change in other current liabilities
----
----
----
----
-125.00%-3K
----
----
--0
---27K
--12K
-Change in other working capital
-314.38%-313K
120.17%146K
-180.80%-724K
-20.18%360K
-553.85%-59K
320.66%896K
-89.00%22K
319.25%410K
292.17%451K
-84.71%13K
Cash from discontinued investing activities
Operating cash flow
27.66%-11.13M
34.84%-15.39M
-15.91%-23.61M
-31.31%-7.49M
-93.64%-7.19M
-64.62%-20.37M
-97.06%-5.7M
-103.68%-5.26M
-1.68%-5.7M
-187.01%-3.71M
Investing cash flow
Cash flow from continuing investing activities
134.65%5.39M
-85.53%2.3M
-18.71%15.88M
-347.13%-4.27M
505.88%14.43M
143.23%19.53M
147.75%9.35M
221.48%6.07M
108.38%1.73M
119,200.00%2.38M
Net PPE purchase and sale
---3K
--0
95.59%-3K
81.82%-2K
92.86%-1K
71.06%-68K
99.23%-1K
---42K
89.22%-11K
-366.67%-14K
Net investment purchase and sale
----
----
----
-345.45%-4.27M
502.38%14.43M
----
----
----
--1.74M
--2.4M
Net other investing changes
134.78%5.39M
-85.54%2.3M
-18.97%15.88M
----
----
143.61%19.6M
148.07%9.35M
----
----
----
Cash from discontinued investing activities
Investing cash flow
134.65%5.39M
-85.53%2.3M
-18.71%15.88M
-347.13%-4.27M
505.88%14.43M
143.23%19.53M
147.75%9.35M
221.48%6.07M
108.38%1.73M
119,200.00%2.38M
Financing cash flow
Cash flow from continuing financing activities
-27.47%7.16M
181.62%9.87M
533.66%3.5M
-101.32%-808K
-972.84%-869K
154.17%39K
Net common stock issuance
-27.59%7.15M
181.62%9.87M
468.45%3.5M
----
----
-101.62%-951K
-945.05%-951K
--0
----
----
Proceeds from stock option exercised by employees
--12K
--0
--0
----
----
1,330.00%143K
720.00%82K
--39K
----
----
Cash from discontinued financing activities
Financing cash flow
-27.47%7.16M
181.62%9.87M
533.66%3.5M
6,118.18%1.37M
--0
-101.32%-808K
-972.84%-869K
154.17%39K
-99.84%22K
--0
Net cash flow
Beginning cash position
-34.38%6.15M
-31.10%9.37M
-10.79%13.6M
49.81%20.84M
-10.79%13.6M
29.97%15.24M
-71.38%10.82M
-78.09%9.96M
-76.11%13.91M
29.97%15.24M
Current changes in cash
143.99%1.42M
23.82%-3.22M
-157.02%-4.23M
-162.80%-10.39M
645.22%7.25M
-146.81%-1.65M
112.32%2.78M
111.21%858K
69.08%-3.95M
-102.86%-1.33M
End cash Position
23.05%7.56M
-34.38%6.15M
-31.10%9.37M
4.98%10.46M
49.81%20.84M
-10.79%13.6M
-10.79%13.6M
-71.38%10.82M
-78.09%9.96M
-76.11%13.91M
Free cash flow
27.64%-11.13M
34.84%-15.39M
-15.54%-23.61M
-31.09%-7.49M
-92.94%-7.19M
-62.04%-20.44M
-88.38%-5.7M
-105.31%-5.3M
-0.05%-5.71M
-187.42%-3.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 27.66%-11.13M34.84%-15.39M-15.91%-23.61M-31.31%-7.49M-93.64%-7.19M-64.62%-20.37M-97.06%-5.7M-103.68%-5.26M-1.68%-5.7M-187.01%-3.71M
Net income from continuing operations 35.50%-9M42.43%-13.95M12.39%-24.22M-28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M
Depreciation and amortization 32.08%70K-20.90%53K15.52%67K14.29%16K23.08%16K70.59%58K27.27%14K88.89%17K100.00%14K85.71%13K
Other non cash items --7K------------------------------------
Change In working capital -34.30%-2.84M-122.68%-2.11M-123.66%-948K40.21%-171K110.87%1.07M305.59%4.01M61.62%1.82M3,280.65%1.97M91.52%-286K40.17%506K
-Change in receivables -134.70%-1.14M-153.93%-487K1,510.94%903K99.73%-3K324.24%814K96.89%-64K516.09%536K129.95%883K56.69%-1.12M-736.84%-363K
-Change in payables and accrued expense 22.09%-1.38M-57.05%-1.77M-135.50%-1.13M-229.51%-531K-62.68%315K3,152.88%3.18M48.56%1.24M362.16%679K145.56%410K285.39%844K
-Change in other current liabilities -----------------125.00%-3K----------0---27K--12K
-Change in other working capital -314.38%-313K120.17%146K-180.80%-724K-20.18%360K-553.85%-59K320.66%896K-89.00%22K319.25%410K292.17%451K-84.71%13K
Cash from discontinued investing activities
Operating cash flow 27.66%-11.13M34.84%-15.39M-15.91%-23.61M-31.31%-7.49M-93.64%-7.19M-64.62%-20.37M-97.06%-5.7M-103.68%-5.26M-1.68%-5.7M-187.01%-3.71M
Investing cash flow
Cash flow from continuing investing activities 134.65%5.39M-85.53%2.3M-18.71%15.88M-347.13%-4.27M505.88%14.43M143.23%19.53M147.75%9.35M221.48%6.07M108.38%1.73M119,200.00%2.38M
Net PPE purchase and sale ---3K--095.59%-3K81.82%-2K92.86%-1K71.06%-68K99.23%-1K---42K89.22%-11K-366.67%-14K
Net investment purchase and sale -------------345.45%-4.27M502.38%14.43M--------------1.74M--2.4M
Net other investing changes 134.78%5.39M-85.54%2.3M-18.97%15.88M--------143.61%19.6M148.07%9.35M------------
Cash from discontinued investing activities
Investing cash flow 134.65%5.39M-85.53%2.3M-18.71%15.88M-347.13%-4.27M505.88%14.43M143.23%19.53M147.75%9.35M221.48%6.07M108.38%1.73M119,200.00%2.38M
Financing cash flow
Cash flow from continuing financing activities -27.47%7.16M181.62%9.87M533.66%3.5M-101.32%-808K-972.84%-869K154.17%39K
Net common stock issuance -27.59%7.15M181.62%9.87M468.45%3.5M---------101.62%-951K-945.05%-951K--0--------
Proceeds from stock option exercised by employees --12K--0--0--------1,330.00%143K720.00%82K--39K--------
Cash from discontinued financing activities
Financing cash flow -27.47%7.16M181.62%9.87M533.66%3.5M6,118.18%1.37M--0-101.32%-808K-972.84%-869K154.17%39K-99.84%22K--0
Net cash flow
Beginning cash position -34.38%6.15M-31.10%9.37M-10.79%13.6M49.81%20.84M-10.79%13.6M29.97%15.24M-71.38%10.82M-78.09%9.96M-76.11%13.91M29.97%15.24M
Current changes in cash 143.99%1.42M23.82%-3.22M-157.02%-4.23M-162.80%-10.39M645.22%7.25M-146.81%-1.65M112.32%2.78M111.21%858K69.08%-3.95M-102.86%-1.33M
End cash Position 23.05%7.56M-34.38%6.15M-31.10%9.37M4.98%10.46M49.81%20.84M-10.79%13.6M-10.79%13.6M-71.38%10.82M-78.09%9.96M-76.11%13.91M
Free cash flow 27.64%-11.13M34.84%-15.39M-15.54%-23.61M-31.09%-7.49M-92.94%-7.19M-62.04%-20.44M-88.38%-5.7M-105.31%-5.3M-0.05%-5.71M-187.42%-3.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -